Update on COVID-19 linked substandard and falsified medical products from IDDO – January & February issues

The Medicine Quality Research Group, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine and the University of Oxford have released their latest Medical Product Quality Report – COVID-19 issues, with results from February 2021. In this issue, 55 new alerts on COVID-19 products were reported on the Medicines Read more…

Kyoto Crime Congress agrees declaration to tackle growing crime threats including falsified and substandard medical products

On 7 March 2021 began the 14th UN Congress on Crime Prevention and Criminal Justice in Kyoto, Japan, with the aim of renewing global cooperation against crime to achieve the Sustainable Development Goals and recover from the pandemic. The Kyoto Declaration was adopted during the event where governments agreed to Read more…

Update on COVID-19 linked substandard and falsified medical products from IDDO – December 2020

The latest ‘Medical Product Quality Report – COVID-19 Issues’ from Medicine Quality Research Group, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine and the University of Oxford from December 2020 highlights the rise of substandard and falsified medicines linked to COVID-19. Throughout 2020 the MQM Globe database tracked and identified over Read more…

Call to Heads of State of the African Union to Ratify the African Medicines Agency Treaty

PRESS RELEASE Patients, product development partnerships and private health sector representatives call for the rapid ratification of the African Medicines Agency Treaty to speed up timelines to vaccines and medicines approval London / Geneva, 5 February 2021 – On the eve of the 34th African Union Summit, two years after Read more…